Zhejiang Yongtai Technology Co Ltd

Yongtai Technology released its 2026 interim report. The company's total operating revenue was 3.746 billion yuan, net profit attributable to the parent company was 274 million yuan, and net cash inflow from operating activities was 579 million yuan. The company's latest asset-liability ratio was 75.23 percent, up 1.71 percentage points from the same period last year. Gross margin was 25.01 percent, return on equity was 9.26 percent, and diluted earnings per share was 0.30 yuan. Total asset turnover was 0.31 times, and inventory turnover was 2.26 times. The number of shareholders was 131,300, and the top ten shareholders held 31.75 percent of the total share capital.

Tiantong Corporation plans to invest 434 million yuan through a wholly-owned subsidiary to build an intelligent manufacturing project with an annual output of 14,600 tonnes of high-end soft magnetic new materials, with a construction period of about 36 months. Zhonghong Medical's net profit attributable to the parent company in the first half of the year surged 2662.38% year-on-year to 159 million yuan. In addition, several companies released half-year reports, with Hangzhou Cable, Yahua Group, and Yongtai Technology all posting substantial net profit growth. Jingsheng Co.'s self-developed large-size CVD SiC chemical vapour deposition coating complete equipment has passed factory inspection and been delivered to customers. Sino Medical's H-share issuance is being filed with the China Securities Regulatory Commission and is expected to be completed in the first quarter of next year; its HT Supreme drug-eluting stent system has been approved in Paraguay. Institutional seats made net purchases of 656 million yuan in Hengtong Optic-Electric and 168 million yuan in Yangtze Optical Fibre and Cable. Wanxun Automation has made progress in its domestic and overseas semiconductor business layout, and Shandong Haode and Anhui Kaize, controlled by Intco Medical, delivered excellent second-quarter profits.

The trial production plan for the 6,666.6-tonne-per-year VC project of Inner Mongolia Yongtai Chemical, a wholly owned subsidiary of Yongtai Technology, has passed expert review and officially met the conditions for trial production, which will now commence. The project is part of the company's annual 25,000-tonne VC and 5,000-tonne FEC projects. After it comes on stream, the company's total VC capacity will increase from 10,000 tonnes per year to 16,700 tonnes per year, a rise of about two-thirds. The company previously started production at another 5,000-tonne-per-year VC line in November 2025 and signed a supply agreement with CATL for a total of 90,000 tonnes of VC from 2027 to 2029. The company expects net profit attributable to the parent of 265 million to 330 million yuan in the first half of the year, up 350.68% to 461.22% year on year.

Tianqi Materials issued an earnings forecast, projecting that net profit attributable to the parent for the first half of 2026 will rise by 907.84% to 1019.82% year-on-year, while net profit after deducting non-recurring items will increase by 1029.57% to 1157.44%. The company attributed the sharp earnings growth mainly to strong demand for lithium battery electrolytes and lithium hexafluorophosphate, with electrolyte shipments up over 40% year-on-year and capacity utilisation near full. At the same time, an improved supply-demand balance drove electrolyte prices up by more than 70% cumulatively from their 2025 lows. Capchem and Yongtai Technology also disclosed substantial profit increases for the same period, forecasting net profit attributable to the parent to grow by 100.48% to 112.88% and 350.68% to 461.22% respectively. Tianqi Materials also revealed that, based on downstream customer demand, electrolyte production scheduling in the third quarter will increase further quarter-on-quarter, and it will advance expansion and renovation projects at production bases in Jiujiang and Fuding to bolster capacity reserves.